Related Experiment Video
Updated: Aug 24, 2025

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
Discoidin domain receptor 1 regulates ErbB2/ErbB3 signaling in mammary epithelial cells
Andrés Martin Toscani1, Pablo Aguilera2,3, Federico Coluccio Leskow2
1IQUIBICEN-CONICET y Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.
Abstract:
The ErbB2 receptor tyrosine kinase plays a key role in mammary gland development. It forms large clusters which serve as signaling platforms for integration of extracellular information. The discoidin domain receptor (DDR) family are collagen receptor tyrosine kinases which, together with ErbB2, are involved in many physiological and pathological processes. Here, we investigated the interaction of ErbB2 and DDR1 receptors in breast cancer cells. In contrast to beta1-integrin, DDR1 colocalizes with ErbB2 in membrane clusters regardless of their expression levels. We demonstrated that this spatial coexistence is a consequence of the physical interaction between these receptors. In addition, these receptors are coexpressed in the normal mammary gland but not in breast tumor samples. Together, these results present DDR1 as a novel modulator of the ErbB2/ErbB3 signaling pathway.
Insights
Discoidin domain receptor 1 (DDR1) physically interacts with ErbB2 receptor tyrosine kinase in breast cancer cells. This interaction suggests DDR1 modulates ErbB2/ErbB3 signaling, impacting mammary gland development and cancer progression.
Area of Science:
- Cell biology
- Molecular oncology
- Receptor tyrosine kinases
Background:
- ErbB2 receptor tyrosine kinase is crucial for mammary gland development and functions as a signaling platform.
- Discoidin domain receptors (DDRs) are collagen receptor tyrosine kinases implicated in various physiological and pathological processes.
- Both ErbB2 and DDR family members are involved in cell signaling pathways relevant to cancer.
Purpose of the Study:
- To investigate the interaction between ErbB2 and DDR1 receptors in breast cancer cells.
- To determine if DDR1 colocalizes with ErbB2 and if this is due to physical interaction.
- To explore the coexpression patterns of these receptors in normal and cancerous mammary tissues.
Main Methods:
- Cell culture of breast cancer cells.
- Immunofluorescence microscopy to assess receptor colocalization.
- Co-immunoprecipitation assays to confirm physical interaction.
- Analysis of tissue samples (normal mammary gland vs. breast tumors).
Main Results:
- DDR1 colocalizes with ErbB2 in membrane clusters in breast cancer cells, irrespective of their expression levels.
- This spatial coexistence is driven by a direct physical interaction between DDR1 and ErbB2.
- DDR1 and ErbB2 are coexpressed in the normal mammary gland but show altered expression in breast tumors.
- DDR1 acts as a novel modulator of the ErbB2/ErbB3 signaling pathway.
Conclusions:
- DDR1 physically interacts with ErbB2 in breast cancer cells, forming signaling platforms.
- The interaction between DDR1 and ErbB2 suggests a role for DDR1 in regulating ErbB2-mediated signaling.
- DDR1 represents a potential therapeutic target or biomarker in breast cancer, particularly concerning ErbB2/ErbB3 pathways.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Mitogens and the Cell Cycle
Master Transcription Regulators
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

